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Abstract
Background: In view of the fact that a significant proportion of neonates with malaria may be
missed on our wards on the assumption that the disease condition is rare, this study aims at
documenting the prevalence of malaria in neonates admitted into our neonatal ward. Specifically,
we hope to describe its clinical features and outcome of this illness. Knowledge of these may ensure
early diagnosis and institution of prompt management.
Methods: Methods Hospital records of all patients (two hundred and thirty) admitted into the
Neonatal ward of Olabisi Onabanjo University Teaching Hospital, Sagamu between 1st January
1998 and 31st December 1999 were reviewed. All neonates (fifty-seven) who had a positive blood
smear for the malaria parasite were included in the study. Socio-demographic data as well as clinical
correlates of each of the patients were reviewed. The Epi-Info 6 statistical software was used for
data entry, validation and analysis. A frequency distribution was generated for categorical variables.
To test for an association between categorical variables, the chi-square test was used. The level of
significance was put at values less than 5%.
Results: Prevalence of neonatal malaria in this study was 24.8% and 17.4% for congenital malaria.
While the mean duration of illness was 3.60 days, it varied from 5.14 days in those that died and
and 3.55 in those that survived respectively. The duration of illness significantly affected the
outcome (p value = 0.03). Fever alone was the clinical presentation in 44 (77.4%) of the patients.
Maturity of the baby, sex and age did not significantly affect infestation. However, history of malaria/
febrile illness within the 2 weeks preceding the delivery was present in 61.2% of the mothers.
Maternal age, concurrent infection and duration of illness all significantly affected the outcome of
illness. Forty-two (73.7%) of the babies were discharged home in satisfactory condition.
Conclusion: It was concluded that taking a blood smear to check for the presence of the malaria
parasite should be included as part of routine workup for all neonates with fever or those whose
mothers have history of fever two weeks prior to delivery. In addition, health education of pregnant
mothers in the antenatal clinic should include early care-seeking for newborns.
Background
Malaria has been recognised as a leading cause of infant
morbidity and mortality in Africans [1] but neonatal
malaria was thought to be rare. This was thought to be
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partly due to the protective effect of Hb F on the neonates
[2]. Recent report however seems to suggest that malaria
is not as rare among newborn infants in Sub-Saharan
Africa as previously thought. In a series, prevalence of con-
genital malaria was put at 7% with a range of 0–23% [3].
Congenital malaria has been shown to occur in children
of clinically healthy mothers who are delivered in malaria
endemic- areas [4].
As clinical signs of neonatal malaria may be indistinguish-
able from that of neonatal sepsis, it has been suggested
that screening for malaria parasite be included as part of
routine investigation in newborn infants with fever [5].
Sometimes, the inability of clinicians to exercise that
index of suspicion for congenital malaria has unwittingly
increased the duration of hospital stay of the neonate or
led to an increase in neonatal mortality.
The burden of malaria in non-malarious countries had led
to the suggestion by workers that neonatal malaria is to be
considered in those newborns with congenital infection
born to mothers who had travelled to endemic areas, even
when they appear clinically healthy [6,7].
A cursory observation on our neonatal ward suggests that
malaria may not be uncommon in this environment.
However, lack of scientific documentation has hindered
the development of a definite policy on case management
of neonatal malaria in our hospital.
Hence, this study aims at documenting the prevalence of
diagnosed malaria in neonates admitted into our neona-
tal ward and description of its clinical features. In addi-
tion, we sought to determine the contributory factors to
the outcome of the illness.
This we hope may ensure early diagnosis and institution
of prompt management.
Methods
This is a retrospective descriptive study. Case notes of all
patients admitted into the Neonatal ward of Olabisi Ona-
banjo University Teaching Hospital, Sagamu, Ogun State,
Western Nigeria between 1st  January 1998 and 31st
December 1999 were reviewed. This is the Teaching Hos-
pital of the Olabisi Onabanjo University. The bed capacity
of the neonatal ward is twenty-six (26).
Majority of the babies admitted into the ward are referred
from the nearby general hospital and private hospitals
within and outside the state. The only routine investiga-
tion in the unit is a sepsis work-up that is usually done in
the service laboratory of the teaching Hospital. (Blood to
be cultured are sent to the laboratory in 2 bottles, one con-
taining the Glucose broth and the other the Thio-glycolate
medium. This is incubated at 37°C for 48 hours. Growth
in either of the medium is sub-cultured on Mc-Conkey,
blood or chocolate agar and further tested for antibiotic
sensitivity. However, if no growth is observed, further
incubation is done for another 48 hours. Other investiga-
tions are determined by clinical presentations.
As with all other laboratory investigations in the hospital,
blood smear for malaria parasite are examined in the serv-
ice laboratory of the hospital by trained laboratory tech-
nologists; Thick and thin blood smear are examined after
staining with Giemsa stain. Samples are considered nega-
tive after searching through 100 microscopic fields). All
neonates whose record indicate positive blood smear for
malaria parasite were included in this study. (no record of
density of parasitemia was available).
Other data extracted from such baby's record included:
age at onset of symptoms (days), sex, birth weight, length,
place of delivery, presenting problem that immediately
led to blood investigation for malaria parasite and dura-
tion of illness, assessed or known gestational age, as well
as treatment regimen given and outcome of illness.
Results of laboratory investigations viz: blood culture, full
blood count and erythrocyte sedimentation rate were
reviewed as well. The mothers' age, parity, history of
febrile illness/malaria at least 2 weeks preceding the deliv-
ery and educational level were retrieved from the case
notes.
For the purpose of the study, Neonatal malaria is defined
as symptoms attributable only to malaria with evidence of
ring forms of malaria parasite in the erythrocyte of an
infant within the first twenty-eight days of life. Congenital
malaria is defined as symptoms attributable only to
malaria with evidence of ring forms of malaria parasite in
the erythrocytes of an infant within the first seven days of
life.
The Epi-Info 6 statistical software was used for data entry,
validation and analysis. Frequency distribution was gener-
ated for categorical variables. To test for association
between categorical variables, the chi-square test was
used. Level of significance was put at values less than 5%.
Results
Fifty-seven (24.8%) of the two hundred and thirty admis-
sions into the neonatal ward in the period under review
had a positive blood smear for malaria parasite. Eighty-
nine out of the two hundred and thirty admissions were
screened for malaria (38.7%).
Those with positive blood smears were aged 1–28 days.
Forty (70.2%) of the babies were aged 7 days or less and
twenty- five (43.3%) were less than 48 hours old at theBMC Pediatrics 2006, 6:19 http://www.biomedcentral.com/1471-2431/6/19
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time of presentation. The mean age was 6.7 days. There
were 35 males and 22 females giving a male: female ratio
of 1.6: 1. Infestation is not sex-linked (p-value = 0.33).
Almost forty- four percent (43.9%) of the babies weighed
less than 2.5 kg and 56.1% were more than 2.5 kg at the
time of presentation. Mean weight was 2.58 kg. Length of
73.2 % of the babies was less than 48 cm. Mean length
was 44.29 (SD 4.33).)
As shown in table 1, 31 (54.4%) of the babies presented
within 3 days of onset of illness and 52 (91%) within 7
days. The mean duration of illness was 3.6 days.
As shown in table 2, fever was the presenting feature in
78.3 % of the babies, 6.7 % of them were hypothermic
and were not feeding well. In all, 10% of them were either
not tolerating feeds or refusing feeds.
Twenty- eight of the babies were delivered in public hos-
pitals while 21 were delivered in private hospitals and the
others were delivered elsewhere. The place of delivery did
not significantly affect infestation. (p-value = 0.99)
While 21 of the babies were pre-term, 25 were full-term
and maturity was not documented in eleven (11) of the
babies. Forty- two (42) of the babies were however appro-
priate for age and 10 were small for date. There was no sig-
nificant difference in the rate of infestation between pre-
term and full-term babies (p value 0.896).
Three of the mothers were aged between 15–20 years,
Seven, between 21 and 25 years and 14 were between 26–
35 years. Maternal age was not documented in 23 cases.
Maternal educational level was documented in only six
cases. Febrile illness within the last trimester of the preg-
nancy was present in 30 out of the 40 cases in whom there
are records. No information was however recorded for 17
cases. Infestation is significantly higher in babies of moth-
ers with history of febrile illness (p value = 0.02).
Only 27 of the mothers were primipara, 20 were multi-
para, 3 Grand multipara. The parity of 7 of the mothers
was not stated.
No hematological evidence of bacterial infection was
found in 96.4% of the babies and thirty – seven (64.9%)
had Packed Cell Volume (PCV) between 30–45%. None
of them had Packed Cell Volume (PCV) less than 20%.
Table 3 shows the treatment and outcome of illness.
Fifty of the babies were treated with appropriate doses of
chloroquine (25 mg chloroquine base/kg), one had Sulf-
adoxine-Pyrimethamine (SP). No treatment was docu-
mented in 6 cases. Forty-two of the babies responded to
the antimalarial given and were subsequently discharged
home in satisfactory condition. Four died and 11 were dis-
charged against medical advice.
The duration of fever in those that died was longer than 5
days. This significantly affected the outcome of illness (p
value = 0.02). Also, concurrent bacterial infection and
maternal age significantly affected the outcome of illness
(p values 0.02 and 0.04 respectively). Three out of the 4
deaths occurred in the babies of mothers aged 15–20
years. Apart from history of febrile illness in the mother
within two weeks prior to delivery, none of the other fac-
tors examined is significantly associated with infestation.
Discussion
This study has identified a prevalence of 24.8 % for diag-
nosed neonatal malaria and 17.4% for congenital
malaria. This is in keeping with an African survey on con-
genital malaria that had reported values of 0–23% [3]. It
is also noteworthy that almost half of the neonates were
less than 48 hours old as at the time of presentation.
Could this have been a reflection of the social class of the
mothers? Unfortunately, documentation of the educa-
tional levels of the mothers was too scanty to make any
reasonable deduction. However, other studies from our
centre have shown that majority of mothers that attend
the facility are in the low to middle socio-economic group
(8). This is not unexpected considering the fact that the
centre is in a semi-urban cosmopolitan setting.
Similar to our findings in this study, a report from western
Uganda has documented that there is no association
between congenital parasitemia and birth weight [9].
Although, over half of the babies in this review presented
within three days of illness, the outcome was found to be
significantly associated with the duration of illness; the
longer the duration the worse the prognosis. This fact has
been demonstrated even in malaria in infancy, where
Table 1: Duration of Illness (days) in the babies
Duration of Illness (Days) Number of cases Cumulative Total Percentage%
1–3 31 54.40
4–7 21 52 91.23
Over 7 05 57 100.0BMC Pediatrics 2006, 6:19 http://www.biomedcentral.com/1471-2431/6/19
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death from severe complicated malaria is discovered to
occur within 2–3 days of illness [10]. The finding of fever
as the main clinical presentation for malaria in this study
is in keeping with the WHO case definition for malaria in
endemic areas [11]. Interestingly, all the features found in
this study are similar to those in neonatal septicaemia. A
study had earlier identified that signs and symptoms of
malaria in the newborn may be indistinguishable from
other neonatal infections [5]. Based on this, it may be
impossible to differentiate one from the other at the bed-
side. Considering the fatality that can result from a delay
in appropriate treatment, it will appear safer to treat all
cases of fever in all children, neonates inclusive, in
malaria -endemic areas with antimalarials while awaiting
the result of investigations.
However, that history of febrile illness in the last trimester
of the pregnancy is significantly associated with infesta-
tion seem to suggest that all babies of such mothers with
such history should be placed under observation in the
neonatal ward and screened for malaria parasite.
The parasitology report of the six babies whose record of
treatment could not be traced was probably retrieved after
their exit from the hospital. They were part of the eleven
that discharged against medical advice. Interestingly, they
gave dissatisfaction with clinical progress of their babies
as reasons for discharge. They had been on admission for
some-time and the blood smear was only requested for
when it appeared that the infants' condition was not
improving.
Maternal age, concurrent bacterial infection and duration
of illness significantly affected the outcome of illness. The
three are interrelated. Babies of teenage mothers are at risk
of neonatal infection. Such mothers may also present late
in the hospital either due to poverty or ignorance.
In conclusion, this study has further confirmed that neo-
natal malaria is not as rare as we had thought in Sub-Saha-
ran Africa. Clinicians need to have a high index of
suspicion so that rapid diagnosis and early appropriate
intervention can be instituted in line with the concept of
Roll Back Malaria.
Conclusion
1. All neonates with features suggestive of neonatal infec-
tion should have blood smear for malaria parasite as part
of their routine screening.
2. All babies of mothers with history of febrile illness
within the last two weeks of pregnancy should have blood
smear for malaria parasite examination.
3. Early care seeking for neonates should be part of the
educational talks in the antenatal clinics.
Table 3: Treatment and Outcome of Illness
Number of Patients
Treatment Discharged Died DAMA* Total
Chloroquin 25 mg base/kg 38 2 10 50
Sulphadoxine- 
Pyrimethamine (SP)
1001
No Record of Treatment 3 2 1 6
Total 42 4 11 57
*DAMA- Discharged Against Medical Advice
Table 2: Frequency of Clinical Features
Clinical Features Frequency%
Temperature> 37.2°C alone 78.3
Temperature<36.5°C+ Not feeding well 6.7
Irritability 5.0
Temperature<35.5°C alone 3.3
Diminished activity+ not feeding well 3.3
Fever, vomiting 1.7
Jitteriness 1.7
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